Long-acting glucagon-like peptide-1 receptor agonist-status December 2018

被引：16
作者：
Holst, Jens Juul [1 ,2 ]
机构：
[1] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-220 Copenhagen, Denmark
[2] Univ Copenhagen, Panum Inst, NNF Ctr Basic Metab Res, DK-220 Copenhagen, Denmark
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷 / 05期
关键词：
BETA-CELL FUNCTION; GLP-1; RECEPTOR; CARDIOVASCULAR OUTCOMES; HEART-FAILURE; DOUBLE-BLIND; FOOD-INTAKE; TYPE-2; LIRAGLUTIDE; GLUCOSE; SEMAGLUTIDE;
D O I：
10.21037/atm.2019.01.09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
[31]   Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist? [J].
Holst, Jens Juul .
LANCET, 2019, 394 (10192) :4-6
[32]   Xenopus-derived glucagon-like peptide-1 and polyethylene-glycosylated glucagon-like peptide-1 receptor agonists: long-acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities [J].
Han, Jing ;
Fei, Yingying ;
Zhou, Feng ;
Chen, Xinyu ;
Zhang, Ying ;
Liu, Lin ;
Fu, Junjie .
BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (03) :544-557
[33]   Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration [J].
van Zuylen, Mark L. ;
Siegelaar, Sarah E. ;
Plummer, Mark P. ;
Deane, Adam M. ;
Hermanides, Jeroen ;
Hulst, Abraham H. .
BRITISH JOURNAL OF ANAESTHESIA, 2024, 132 (04) :644-648
[34]   NEPHROPROTECTIVE POTENTIAL OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS [J].
Shamhalova, Minara S. ;
Sklyanik, Igor A. ;
Shestakova, Marina V. .
DIABETES MELLITUS, 2020, 23 (01) :56-64
[35]   Glucagon-Like Peptide-1 Receptor Agonist Treatment for Pediatric Obesity [J].
Kelly, Aaron S. .
ADVANCED THERAPIES IN PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY, 2016, 30 :23-28
[36]   Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity [J].
Jensterle, Mojca ;
Janez, Andrej .
HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (06) :599-608
[37]   Semaglutide: a promising new glucagon-like peptide-1 receptor agonist [J].
Scheen, Andre J. .
LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (04) :236-238
[38]   Renal protection with glucagon-like peptide-1 receptor agonists [J].
Vitale, Martina ;
Haxhi, Jonida ;
Cirrito, Tiziana ;
Pugliese, Giuseppe .
CURRENT OPINION IN PHARMACOLOGY, 2020, 54 :91-101
[39]   Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes [J].
Rizzo, Manfredi ;
Rizvi, Ali A. ;
Sesti, Giorgio .
DIABETES OBESITY & METABOLISM, 2017, 19 (05) :613-614
[40]   Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes? [J].
Updike, Wendy H. ;
Pane, Olivia ;
Franks, Rachel ;
Saber, Faizah ;
Abdeen, Farah ;
Balazy, Derek D. ;
Carris, Nicholas W. .
DRUGS, 2021, 81 (08) :881-893
12345